Clinical Trial Update: Malaria Challenge With NF54 Strain [Phase 1]

View source ↗

Summary

A Phase 1 malaria-challenge trial using the Plasmodium falciparum NF54 strain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Infection | Phase 1 | Status: COMPLETED